|
The Latest Breakthroughs in Immunotherapy for GU Cancers Podcast (2023) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:The Latest Breakthroughs in Immunotherapy for GU Cancers (2023) |
|
Update Series (2015) Lesson 4: Natural Medicine for Early Prostate Cancer |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Treatment for Hormone Sensitive Prostate Cancer Webcast (2023) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
|
|
Germline Testing in GU Cancers – How I Do It Podcast (2023) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Germline Testing in GU Cancers – How I Do It (2023) |
|
Update Series (2015) Lesson 5: Genetics of Renal Cancer and Treatment Implications |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Advances in ADT: Part II: A Guide for Urologists (2023) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
09/28/2023 |
$0.00 |
|
|
PARPi: Precision Medicine in Advanced Prostate Cancer Webcast (2023) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. |
|
Update Series (2016) Lesson 2: Prostate Cryotherapy |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™ |
|
Update Series (2015) Lesson 8: Management of Atypical Urine Cytology |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Advances in ADT: Part II: A Guide for APPs (2023) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
09/26/2023 |
$0.00 |
|
|
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. |
|
Update Series (2016) Lesson 7: Urological Evaluation of the Transplant Recipient |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™ |
|
Update Series (2015) Lesson 10: Clinical Stage I Testicular Cancer |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects Podcast (2023) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is offering phase two of an educational series to update urologists and advanced practice providers (APPs) on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. Part II will consist of two live webinars, one designed specifically for urologists and the other for APPs. The live virtual courses will feature a multidisciplinary panel engaging in a lively discussion on this topic. |
|
PARPi: Management of Adverse Events Webcast (2024) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. |
Facebook
Twitter
LinkedIn
Forward